(2R,3R,4S,5R)-2-(6-amino-2-iodopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol CAS:35109-88-7

Are you looking for trusted manufacturer or supplier of CAS:35109-88-7 (2R,3R,4S,5R)-2-(6-amino-2-iodopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol? Why not just drop an inquiry to info@nbinno.com or visit www.nbinno.com our official website?


(2R,3R,4S,5R)-2-(6-amino-2-iodopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol manufacturer in India China

Chemical Name:(2R,3R,4S,5R)-2-(6-amino-2-iodopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
CAS.NO:35109-88-7
Synonyms:2-IODOADENOSINE
2-iodo-2',3'-O-isopropylidene-adenosine
Adenosine,2-iodo
2-idodadenosine
6-Amino-2-iodo-9-(β-D-ribofuranosyl)purine
Molecular Formula:C10H12IN5O4
Molecular Weight:393.13800
 
Physical and Chemical Properties:
Density:2.69
Melting point:200ºC
Boiling point:776.3ºC
Flash point:423.3ºC
Index of Refraction:1.994
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:An intermediates in the synthesis of isoguanosine (crotonoside or 2-hydroxyadenosine), a naturally occuring nucleoside analogue of guanosine. Isoguanosine is incorporated into mammalian but not bacterial nucleic acids, stimulates the accumulation of cyclic AMP in the brain, and is an inhibitor of IMP:pyrophosphorylase.



2-IODOADENOSINE Certificate of analysis (COA),(2R,3R,4S,5R)-2-(6-Amino-2-Iodopurin-9-Yl)-5-(Hydroxymethyl)Oxolane-3,4-Diol Specification,2-IODOADENOSINE Safety Data Sheet (MSDS),6-Amino-2-iodo-9-(β-D-ribofuranosyl)purine NMR,6-Amino-2-iodo-9-(β-D-ribofuranosyl)purine Route of synthesis (ROS),(2R,3R,4S,5R)-2-(6-amino-2-iodopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Method of Anasis (MOA),2-IODOADENOSINE manufacturers,(2R,3R,4S,5R)-2-(6-Amino-2-Iodopurin-9-Yl)-5-(Hydroxymethyl)Oxolane-3,4-Diol suppliers,CAS 35109-88-7 manufacturers.


Related News: Given ICER’s uncertainty regarding efgartigimod’s dosing and long-term benefits, the group said it’s moderately certain the drug can produce a “comparable, small or substantial net health benefit” in that same group of MG patients. L-Tyrosine, N-(2-benzoyl-1-cyclohexen-1-yl)-O-(phenylmethyl)- manufacturer It has also been possible to prepare enzymes that can function effectively in organic solvents, thereby dramatically increasing the number of reactions possible. 10-methyl-11b-phenyl-1,2,3,5,6,11b-hexahydrobenzo[f]pyrrolo[1,2-d][1,4]thiazepine hydrochloride supplier The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. 1-ethyl-3-(6-(1-ethyl-2-oxo-1,2-dihydropyridin-4-yl)-4-(1H-pyrazol-1-yl)-1H-benzo[d]imidazol-2-yl)urea producer.